カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の腫瘍用ジェネリック注射剤市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Oncology Generic Injectable Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19471）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19471
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：95
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の腫瘍用ジェネリック注射剤市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

腫瘍用ジェネリック注射剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の腫瘍用ジェネリック注射剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

腫瘍用ジェネリック注射剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・高分子医薬品、低分子医薬品

用途別セグメントは次のように区分されます。
・病院調剤薬局、小売調剤薬局、オンライン調剤薬局

世界の腫瘍用ジェネリック注射剤市場の主要な市場プレーヤーは以下のとおりです。
・Teva Pharmaceutical、Pfizer、AstraZeneca、Roche、Eli Lilly、GlaxoSmithKline、Novartis、Mylan、Natco Pharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、腫瘍用ジェネリック注射剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な腫瘍用ジェネリック注射剤メーカーの企業概要、2019年～2022年までの腫瘍用ジェネリック注射剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な腫瘍用ジェネリック注射剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別腫瘍用ジェネリック注射剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの腫瘍用ジェネリック注射剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での腫瘍用ジェネリック注射剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および腫瘍用ジェネリック注射剤の産業チェーンを掲載しています。
・第13、14、15章では、腫瘍用ジェネリック注射剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 腫瘍用ジェネリック注射剤の概要
- 種類別分析（2017年vs2021年vs2028年）：高分子医薬品、低分子医薬品
- 用途別分析（2017年vs2021年vs2028年）：病院調剤薬局、小売調剤薬局、オンライン調剤薬局
- 世界の腫瘍用ジェネリック注射剤市場規模・予測
- 世界の腫瘍用ジェネリック注射剤生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Teva Pharmaceutical、Pfizer、AstraZeneca、Roche、Eli Lilly、GlaxoSmithKline、Novartis、Mylan、Natco Pharma
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：高分子医薬品、低分子医薬品
・用途別分析2017年-2028年：病院調剤薬局、小売調剤薬局、オンライン調剤薬局
・腫瘍用ジェネリック注射剤の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・腫瘍用ジェネリック注射剤のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・腫瘍用ジェネリック注射剤のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・腫瘍用ジェネリック注射剤の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・腫瘍用ジェネリック注射剤の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Oncology Generic Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oncology Generic Injectable Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Oncology Generic Injectable Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Large Molecule Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oncology Generic Injectable Drugs include Teva Pharmaceutical, Pfizer, AstraZeneca, Roche, and Eli Lilly, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oncology Generic Injectable Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Large Molecule Drugs
Small Molecule Drugs
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The key market players for global Oncology Generic Injectable Drugs market are listed below:
Teva Pharmaceutical
Pfizer
AstraZeneca
Roche
Eli Lilly
GlaxoSmithKline
Novartis
Mylan
Natco Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oncology Generic Injectable Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oncology Generic Injectable Drugs, with price, sales, revenue and global market share of Oncology Generic Injectable Drugs from 2019 to 2022.
Chapter 3, the Oncology Generic Injectable Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology Generic Injectable Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oncology Generic Injectable Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology Generic Injectable Drugs.
Chapter 13, 14, and 15, to describe Oncology Generic Injectable Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Oncology Generic Injectable Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oncology Generic Injectable Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Large Molecule Drugs
1.2.3 Small Molecule Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Oncology Generic Injectable Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Oncology Generic Injectable Drugs Market Size & Forecast
1.4.1 Global Oncology Generic Injectable Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Oncology Generic Injectable Drugs Sales in Volume (2017-2028)
1.4.3 Global Oncology Generic Injectable Drugs Price (2017-2028)
1.5 Global Oncology Generic Injectable Drugs Production Capacity Analysis
1.5.1 Global Oncology Generic Injectable Drugs Total Production Capacity (2017-2028)
1.5.2 Global Oncology Generic Injectable Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncology Generic Injectable Drugs Market Drivers
1.6.2 Oncology Generic Injectable Drugs Market Restraints
1.6.3 Oncology Generic Injectable Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Teva Pharmaceutical
2.1.1 Teva Pharmaceutical Details
2.1.2 Teva Pharmaceutical Major Business
2.1.3 Teva Pharmaceutical Oncology Generic Injectable Drugs Product and Services
2.1.4 Teva Pharmaceutical Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Oncology Generic Injectable Drugs Product and Services
2.2.4 Pfizer Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Oncology Generic Injectable Drugs Product and Services
2.3.4 AstraZeneca Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Oncology Generic Injectable Drugs Product and Services
2.4.4 Roche Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly Oncology Generic Injectable Drugs Product and Services
2.5.4 Eli Lilly Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Oncology Generic Injectable Drugs Product and Services
2.6.4 GlaxoSmithKline Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Oncology Generic Injectable Drugs Product and Services
2.7.4 Novartis Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Oncology Generic Injectable Drugs Product and Services
2.8.4 Mylan Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Natco Pharma
2.9.1 Natco Pharma Details
2.9.2 Natco Pharma Major Business
2.9.3 Natco Pharma Oncology Generic Injectable Drugs Product and Services
2.9.4 Natco Pharma Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Oncology Generic Injectable Drugs Breakdown Data by Manufacturer
3.1 Global Oncology Generic Injectable Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Oncology Generic Injectable Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Oncology Generic Injectable Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Oncology Generic Injectable Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Oncology Generic Injectable Drugs Manufacturer Market Share in 2021
3.5 Global Oncology Generic Injectable Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Oncology Generic Injectable Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oncology Generic Injectable Drugs Market Size by Region
4.1.1 Global Oncology Generic Injectable Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Oncology Generic Injectable Drugs Revenue by Region (2017-2028)
4.2 North America Oncology Generic Injectable Drugs Revenue (2017-2028)
4.3 Europe Oncology Generic Injectable Drugs Revenue (2017-2028)
4.4 Asia-Pacific Oncology Generic Injectable Drugs Revenue (2017-2028)
4.5 South America Oncology Generic Injectable Drugs Revenue (2017-2028)
4.6 Middle East and Africa Oncology Generic Injectable Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Oncology Generic Injectable Drugs Sales in Volume by Type (2017-2028)
5.2 Global Oncology Generic Injectable Drugs Revenue by Type (2017-2028)
5.3 Global Oncology Generic Injectable Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Oncology Generic Injectable Drugs Sales in Volume by Application (2017-2028)
6.2 Global Oncology Generic Injectable Drugs Revenue by Application (2017-2028)
6.3 Global Oncology Generic Injectable Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Oncology Generic Injectable Drugs Sales by Type (2017-2028)
7.2 North America Oncology Generic Injectable Drugs Sales by Application (2017-2028)
7.3 North America Oncology Generic Injectable Drugs Market Size by Country
7.3.1 North America Oncology Generic Injectable Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Oncology Generic Injectable Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Oncology Generic Injectable Drugs Sales by Type (2017-2028)
8.2 Europe Oncology Generic Injectable Drugs Sales by Application (2017-2028)
8.3 Europe Oncology Generic Injectable Drugs Market Size by Country
8.3.1 Europe Oncology Generic Injectable Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Oncology Generic Injectable Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Oncology Generic Injectable Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Oncology Generic Injectable Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Oncology Generic Injectable Drugs Market Size by Region
9.3.1 Asia-Pacific Oncology Generic Injectable Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Oncology Generic Injectable Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Oncology Generic Injectable Drugs Sales by Type (2017-2028)
10.2 South America Oncology Generic Injectable Drugs Sales by Application (2017-2028)
10.3 South America Oncology Generic Injectable Drugs Market Size by Country
10.3.1 South America Oncology Generic Injectable Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Oncology Generic Injectable Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oncology Generic Injectable Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Oncology Generic Injectable Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Oncology Generic Injectable Drugs Market Size by Country
11.3.1 Middle East & Africa Oncology Generic Injectable Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Oncology Generic Injectable Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Oncology Generic Injectable Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Oncology Generic Injectable Drugs
12.3 Oncology Generic Injectable Drugs Production Process
12.4 Oncology Generic Injectable Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oncology Generic Injectable Drugs Typical Distributors
13.3 Oncology Generic Injectable Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Oncology Generic Injectable Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Oncology Generic Injectable Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Teva Pharmaceutical Major Business
Table 5. Teva Pharmaceutical Oncology Generic Injectable Drugs Product and Services
Table 6. Teva Pharmaceutical Oncology Generic Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Oncology Generic Injectable Drugs Product and Services
Table 10. Pfizer Oncology Generic Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 12. AstraZeneca Major Business
Table 13. AstraZeneca Oncology Generic Injectable Drugs Product and Services
Table 14. AstraZeneca Oncology Generic Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Roche Basic Information, Manufacturing Base and Competitors
Table 16. Roche Major Business
Table 17. Roche Oncology Generic Injectable Drugs Product and Services
Table 18. Roche Oncology Generic Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly Major Business
Table 21. Eli Lilly Oncology Generic Injectable Drugs Product and Services
Table 22. Eli Lilly Oncology Generic Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Oncology Generic Injectable Drugs Product and Services
Table 26. GlaxoSmithKline Oncology Generic Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Novartis Basic Information, Manufacturing Base and Competitors
Table 28. Novartis Major Business
Table 29. Novartis Oncology Generic Injectable Drugs Product and Services
Table 30. Novartis Oncology Generic Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Mylan Basic Information, Manufacturing Base and Competitors
Table 32. Mylan Major Business
Table 33. Mylan Oncology Generic Injectable Drugs Product and Services
Table 34. Mylan Oncology Generic Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Natco Pharma Major Business
Table 37. Natco Pharma Oncology Generic Injectable Drugs Product and Services
Table 38. Natco Pharma Oncology Generic Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Oncology Generic Injectable Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Oncology Generic Injectable Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Oncology Generic Injectable Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Oncology Generic Injectable Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Oncology Generic Injectable Drugs Production Site of Key Manufacturer
Table 44. Oncology Generic Injectable Drugs New Entrant and Capacity Expansion Plans
Table 45. Oncology Generic Injectable Drugs Mergers & Acquisitions in the Past Five Years
Table 46. Global Oncology Generic Injectable Drugs Sales by Region (2017-2022) & (K Units)
Table 47. Global Oncology Generic Injectable Drugs Sales by Region (2023-2028) & (K Units)
Table 48. Global Oncology Generic Injectable Drugs Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Oncology Generic Injectable Drugs Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Oncology Generic Injectable Drugs Sales by Type (2017-2022) & (K Units)
Table 51. Global Oncology Generic Injectable Drugs Sales by Type (2023-2028) & (K Units)
Table 52. Global Oncology Generic Injectable Drugs Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Oncology Generic Injectable Drugs Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Oncology Generic Injectable Drugs Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Oncology Generic Injectable Drugs Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Oncology Generic Injectable Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Global Oncology Generic Injectable Drugs Sales by Application (2023-2028) & (K Units)
Table 58. Global Oncology Generic Injectable Drugs Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Oncology Generic Injectable Drugs Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Oncology Generic Injectable Drugs Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Oncology Generic Injectable Drugs Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Oncology Generic Injectable Drugs Sales by Country (2017-2022) & (K Units)
Table 63. North America Oncology Generic Injectable Drugs Sales by Country (2023-2028) & (K Units)
Table 64. North America Oncology Generic Injectable Drugs Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Oncology Generic Injectable Drugs Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Oncology Generic Injectable Drugs Sales by Type (2017-2022) & (K Units)
Table 67. North America Oncology Generic Injectable Drugs Sales by Type (2023-2028) & (K Units)
Table 68. North America Oncology Generic Injectable Drugs Sales by Application (2017-2022) & (K Units)
Table 69. North America Oncology Generic Injectable Drugs Sales by Application (2023-2028) & (K Units)
Table 70. Europe Oncology Generic Injectable Drugs Sales by Country (2017-2022) & (K Units)
Table 71. Europe Oncology Generic Injectable Drugs Sales by Country (2023-2028) & (K Units)
Table 72. Europe Oncology Generic Injectable Drugs Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Oncology Generic Injectable Drugs Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Oncology Generic Injectable Drugs Sales by Type (2017-2022) & (K Units)
Table 75. Europe Oncology Generic Injectable Drugs Sales by Type (2023-2028) & (K Units)
Table 76. Europe Oncology Generic Injectable Drugs Sales by Application (2017-2022) & (K Units)
Table 77. Europe Oncology Generic Injectable Drugs Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Oncology Generic Injectable Drugs Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Oncology Generic Injectable Drugs Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Oncology Generic Injectable Drugs Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Oncology Generic Injectable Drugs Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Oncology Generic Injectable Drugs Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Oncology Generic Injectable Drugs Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Oncology Generic Injectable Drugs Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Oncology Generic Injectable Drugs Sales by Application (2023-2028) & (K Units)
Table 86. South America Oncology Generic Injectable Drugs Sales by Country (2017-2022) & (K Units)
Table 87. South America Oncology Generic Injectable Drugs Sales by Country (2023-2028) & (K Units)
Table 88. South America Oncology Generic Injectable Drugs Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Oncology Generic Injectable Drugs Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Oncology Generic Injectable Drugs Sales by Type (2017-2022) & (K Units)
Table 91. South America Oncology Generic Injectable Drugs Sales by Type (2023-2028) & (K Units)
Table 92. South America Oncology Generic Injectable Drugs Sales by Application (2017-2022) & (K Units)
Table 93. South America Oncology Generic Injectable Drugs Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Oncology Generic Injectable Drugs Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Oncology Generic Injectable Drugs Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Oncology Generic Injectable Drugs Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Oncology Generic Injectable Drugs Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Oncology Generic Injectable Drugs Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Oncology Generic Injectable Drugs Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Oncology Generic Injectable Drugs Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Oncology Generic Injectable Drugs Sales by Application (2023-2028) & (K Units)
Table 102. Oncology Generic Injectable Drugs Raw Material
Table 103. Key Manufacturers of Oncology Generic Injectable Drugs Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Oncology Generic Injectable Drugs Typical Distributors
Table 107. Oncology Generic Injectable Drugs Typical Customers
List of Figures
Figure 1. Oncology Generic Injectable Drugs Picture
Figure 2. Global Oncology Generic Injectable Drugs Revenue Market Share by Type in 2021
Figure 3. Large Molecule Drugs
Figure 4. Small Molecule Drugs
Figure 5. Global Oncology Generic Injectable Drugs Revenue Market Share by Application in 2021
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Global Oncology Generic Injectable Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Oncology Generic Injectable Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Oncology Generic Injectable Drugs Sales (2017-2028) & (K Units)
Figure 12. Global Oncology Generic Injectable Drugs Price (2017-2028) & (USD/Unit)
Figure 13. Global Oncology Generic Injectable Drugs Production Capacity (2017-2028) & (K Units)
Figure 14. Global Oncology Generic Injectable Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Oncology Generic Injectable Drugs Market Drivers
Figure 16. Oncology Generic Injectable Drugs Market Restraints
Figure 17. Oncology Generic Injectable Drugs Market Trends
Figure 18. Global Oncology Generic Injectable Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Oncology Generic Injectable Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Oncology Generic Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Oncology Generic Injectable Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Oncology Generic Injectable Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Oncology Generic Injectable Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Oncology Generic Injectable Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Oncology Generic Injectable Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Oncology Generic Injectable Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Oncology Generic Injectable Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Oncology Generic Injectable Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Oncology Generic Injectable Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Oncology Generic Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Oncology Generic Injectable Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Oncology Generic Injectable Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Oncology Generic Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Oncology Generic Injectable Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Oncology Generic Injectable Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Oncology Generic Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Oncology Generic Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Oncology Generic Injectable Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Oncology Generic Injectable Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Oncology Generic Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Oncology Generic Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Oncology Generic Injectable Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Oncology Generic Injectable Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Oncology Generic Injectable Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Oncology Generic Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Oncology Generic Injectable Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Oncology Generic Injectable Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Oncology Generic Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Oncology Generic Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Oncology Generic Injectable Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Oncology Generic Injectable Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Oncology Generic Injectable Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Oncology Generic Injectable Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Oncology Generic Injectable Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Oncology Generic Injectable Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Oncology Generic Injectable Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Oncology Generic Injectable Drugs in 2021
Figure 77. Manufacturing Process Analysis of Oncology Generic Injectable Drugs
Figure 78. Oncology Generic Injectable Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の注射用糖尿病治療薬市場2022年：市場規模予測（～2028年）
  • 世界の2型糖尿病用注射剤市場2022年：市場規模予測（～2028年）
  • 世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場2022年：市場規模予測（～2028年）
  • 世界の注射用発作治療薬市場2022年：市場規模予測（～2028年）
  • 世界のペプチド抗生物質無菌注射剤市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19471 )"世界の腫瘍用ジェネリック注射剤市場2022年：市場規模予測（～2028年）" (英文：Global Oncology Generic Injectable Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。